chr3-167794834-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001122752.2(SERPINI1):c.881+10T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00109 in 1,611,036 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0064 ( 17 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 3 hom. )
Consequence
SERPINI1
NM_001122752.2 intron
NM_001122752.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.17
Publications
0 publications found
Genes affected
SERPINI1 (HGNC:8943): (serpin family I member 1) This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
SERPINI1 Gene-Disease associations (from GenCC):
- progressive myoclonus epilepsyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- familial encephalopathy with neuroserpin inclusion bodiesInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 3-167794834-T-G is Benign according to our data. Variant chr3-167794834-T-G is described in ClinVar as Benign. ClinVar VariationId is 466623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00642 (977/152250) while in subpopulation AFR AF = 0.0229 (952/41556). AF 95% confidence interval is 0.0217. There are 17 homozygotes in GnomAd4. There are 447 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 977 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SERPINI1 | NM_001122752.2 | c.881+10T>G | intron_variant | Intron 5 of 8 | ENST00000446050.7 | NP_001116224.1 | ||
| SERPINI1 | NM_005025.5 | c.881+10T>G | intron_variant | Intron 5 of 8 | NP_005016.1 | |||
| SERPINI1 | XM_017006618.3 | c.881+10T>G | intron_variant | Intron 5 of 8 | XP_016862107.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SERPINI1 | ENST00000446050.7 | c.881+10T>G | intron_variant | Intron 5 of 8 | 1 | NM_001122752.2 | ENSP00000397373.2 | |||
| SERPINI1 | ENST00000295777.9 | c.881+10T>G | intron_variant | Intron 5 of 8 | 1 | ENSP00000295777.5 | ||||
| SERPINI1 | ENST00000472747.2 | c.*155T>G | downstream_gene_variant | 3 | ENSP00000420561.2 | |||||
| ENSG00000287319 | ENST00000661269.1 | n.*113A>C | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00638 AC: 971AN: 152132Hom.: 18 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
971
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00162 AC: 405AN: 250770 AF XY: 0.00113 show subpopulations
GnomAD2 exomes
AF:
AC:
405
AN:
250770
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000530 AC: 773AN: 1458786Hom.: 3 Cov.: 30 AF XY: 0.000459 AC XY: 333AN XY: 725870 show subpopulations
GnomAD4 exome
AF:
AC:
773
AN:
1458786
Hom.:
Cov.:
30
AF XY:
AC XY:
333
AN XY:
725870
show subpopulations
African (AFR)
AF:
AC:
672
AN:
33364
American (AMR)
AF:
AC:
25
AN:
44562
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26102
East Asian (EAS)
AF:
AC:
0
AN:
39674
South Asian (SAS)
AF:
AC:
2
AN:
86134
European-Finnish (FIN)
AF:
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
AC:
3
AN:
4756
European-Non Finnish (NFE)
AF:
AC:
7
AN:
1110580
Other (OTH)
AF:
AC:
64
AN:
60212
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00642 AC: 977AN: 152250Hom.: 17 Cov.: 32 AF XY: 0.00600 AC XY: 447AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
977
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
447
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
952
AN:
41556
American (AMR)
AF:
AC:
16
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68002
Other (OTH)
AF:
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Familial encephalopathy with neuroserpin inclusion bodies Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.